Premium
Treatment of basal cell carcinoma
Author(s) -
Wetzig Tino,
Maschke Jan,
Kendler Michael,
Simon Jan C.
Publication year - 2009
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/j.1610-0387.2009.07097.x
Subject(s) - basal cell carcinoma , basal cell , medicine , incidence (geometry) , basal (medicine) , dermatology , oncology , pathology , physics , insulin , optics
Summary Basal cell carcinoma is the most common tumor in Central Europe, the U.S. and Australia. The increasing incidence of basal cell carcinoma presents the health care system, especially dermatology, with great challenges. In recent years new options for treating basal cell carcinoma have become available, enriching our therapeutic options. We review the current status of each of these treatment approaches.